Sensata Technologies (NYSE:ST – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Monday morning. The company provided EPS guidance of 0.710-0.760 for the period, compared to the consensus EPS estimate of 0.850. The company issued revenue guidance of $870.0 million-$900.0 million, compared to the consensus revenue estimate of $957.3 million. Sensata Technologies also updated its Q4 guidance to $0.71-0.76 EPS.
Sensata Technologies Stock Down 2.4 %
NYSE ST traded down $0.84 on Monday, hitting $33.64. The stock had a trading volume of 2,346,150 shares, compared to its average volume of 1,860,234. Sensata Technologies has a 52-week low of $30.56 and a 52-week high of $43.14. The business’s fifty day moving average price is $35.65 and its 200 day moving average price is $37.70. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.77 and a quick ratio of 1.31. The stock has a market cap of $5.08 billion, a price-to-earnings ratio of 841.00, a price-to-earnings-growth ratio of 1.36 and a beta of 1.25.
Sensata Technologies Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.43%. The ex-dividend date is Wednesday, November 13th. Sensata Technologies’s dividend payout ratio is currently 1,200.00%.
Analyst Ratings Changes
Check Out Our Latest Stock Report on ST
About Sensata Technologies
Sensata Technologies Holding plc develops, manufactures, and sells sensors and sensor-rich solutions, electrical protection components and systems, and other products used in mission-critical systems and applications in the United States and internationally. It operates in two segments, Performance Sensing and Sensing Solutions.
Further Reading
- Five stocks we like better than Sensata Technologies
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Intel: Is Now the Time to Be Brave?
- ESG Stocks, What Investors Should Know
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Sensata Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensata Technologies and related companies with MarketBeat.com's FREE daily email newsletter.